These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 9871440)

  • 1. Amantadine for Traumatic Brain Injury-Supporting Evidence and Mode of Action.
    Dekundy A; Pichler G; El Badry R; Scheschonka A; Danysz W
    Biomedicines; 2024 Jul; 12(7):. PubMed ID: 39062131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentials.
    Danysz W; Dekundy A; Scheschonka A; Riederer P
    J Neural Transm (Vienna); 2021 Feb; 128(2):127-169. PubMed ID: 33624170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of amantadine for the treatment of L-DOPA-induced dyskinesia.
    Perez-Lloret S; Rascol O
    J Neural Transm (Vienna); 2018 Aug; 125(8):1237-1250. PubMed ID: 29511826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.
    Wanka L; Iqbal K; Schreiner PR
    Chem Rev; 2013 May; 113(5):3516-604. PubMed ID: 23432396
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancing aromatic L-amino acid decarboxylase activity: implications for L-DOPA treatment in Parkinson's disease.
    Hadjiconstantinou M; Neff NH
    CNS Neurosci Ther; 2008; 14(4):340-51. PubMed ID: 19040557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible new mechanism for the antiparkinsonian effect of amantadine.
    Bennett VL; Juorio AV; Li XM
    J Psychiatry Neurosci; 1999 Jan; 24(1):52-3. PubMed ID: 9987209
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmacology of native N-methyl-D-aspartate receptor subtypes: different receptors control the release of different striatal and spinal transmitters.
    Nankai M; Klarica M; Fage D; Carter C
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jan; 22(1):35-64. PubMed ID: 9533166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamatergic drugs in Parkinson's disease.
    Lange KW; Riederer P
    Life Sci; 1994; 55(25-26):2067-75. PubMed ID: 7997066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of NMDA and non-NMDA antagonists on the activity of aromatic L-amino acid decarboxylase activity in the nigrostriatal dopamine pathway of the rat.
    Fisher A; Biggs CS; Starr MS
    Brain Res; 1998 May; 792(1):126-32. PubMed ID: 9593857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite effects of glutamate antagonists and antiparkinsonian drugs on the activities of DOPA decarboxylase and 5-HTP decarboxylase in the rat brain.
    Fisher A; Starr MS
    Brain Res; 2000 Jun; 868(2):268-74. PubMed ID: 10854579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.
    Löschmann PA; Wüllner U; Heneka MT; Schulz JB; Kunow M; Wachtel H; Klockgether T
    Synapse; 1997 Aug; 26(4):381-91. PubMed ID: 9215597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
    Biggs CS; Fisher A; Starr MS
    Synapse; 1998 Nov; 30(3):309-17. PubMed ID: 9776134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of intrastriatal and intranigral injections of glutamate antagonists on motor behaviour in the reserpine-treated rat.
    Kaur S; Starr MS
    Neuroscience; 1997 Jan; 76(2):345-54. PubMed ID: 9015320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of glutamate antagonists on the activity of aromatic L-amino acid decarboxylase.
    Fisher A; Biggs CS; Starr MS
    Amino Acids; 1998; 14(1-3):43-9. PubMed ID: 9871440
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.